Moderna stock slides as $1.9 billion sales view fails to calm investors (MRNA)
NEW YORK, Jan 12, 2026, 10:25 (ET) — Regular session Moderna (MRNA.O) shares dropped roughly 4% on Monday following the release of updated revenue and expense forecasts ahead of a healthcare investor event. The stock fell $1.38 to $32.92, after starting the day at $34.40 and fluctuating between $35.77 and $32.81. This update is crucial as Moderna works to transition…